IL6 and coronary artery disorder: With recent substantial progress in exploring the progression of coronary atherosclerosis, classic cardiovascular risk factors are inadequate as indicators of disease prediction and stratification (2), and inflammatory biomarkers such as C-reactive protein (CRP) and interleukin-6 (IL-6) have received growing attention in the pathogenesis of CHD (3, 4).